Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
Portfolio Pulse from Benzinga Newsdesk
Viemed Healthcare reported Q1 2024 earnings of $0.04 per share, missing the $0.07 estimate, but sales of $50.593M exceeded the $50.000M forecast, marking a 27.90% increase from the previous year.
May 06, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Viemed Healthcare's Q1 2024 earnings per share were $0.04, missing estimates by 42.86%, but sales of $50.593M beat estimates, showing a 27.90% YOY growth.
The miss in EPS could negatively impact investor sentiment in the short term, but the significant sales beat and year-over-year growth may offset this by demonstrating the company's ability to grow revenue. The mixed results present a neutral outlook, as the positive revenue growth could balance out the negative earnings miss in investors' eyes.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100